GE Healthcare and Parker domnick hunter collaboration in biopharmaceutical purification.
Date:
01/02/2007
Companies to serve biopharmaceutical Market with advanced microfiltration cartridges and devices.
Chalfont St. Giles, UK, and Newcastle, UK, February 1 2007
GE Healthcare and Parker domnick hunter, a division of Parker Hannifin (NYSE:PH) announced today that they have entered into an exclusive agreement for the supply and distribution of products for biopharmaceutical purification. Under the terms of the agreement, GE Healthcare will have exclusive global rights to market a new range of microfiltration cartridges and disposable filters manufactured by Parker domnick hunter. Financial terms were not disclosed.
The new line of disposable filters for liquid filtration applications in biopharmaceutical manufacture will be marketed by GE Healthcare’s global sales and marketing organization under the ULTA™ brand. The products increase the range of technologies available for the purification of vaccines, antibodies and other biomolecules.
"This agreement allows us to expand the range of products for biopharmaceutical purification that we are able to offer our customers,” said Ann O’Hara, General Manager of Bioprocess for GE Healthcare. "Building on our reputation as a supplier of cutting edge technologies, the ULTA™ line of normal flow cartridges will be a significant addition to our purification portfolio”.
"We developed an outstanding line of cartridge filters with an eye to making significant in roads into the pharmaceutical market, expanding on our past successes in this area." said Jeff Porter, Managing Director, Process Division, Europe at Parker domnick hunter. "We are very excited about the prospects of this agreement, which enables us to bring our advanced purification technologies to the biopharmaceutical production industry."
Parker domnick hunter will continue to market its own brand of air and gas filters to the biopharmaceutical industry.
Under a separate joint technology development agreement the two companies will collaborate in the development of new technologies for protein purification, drawing from each other's strengths in separation and purification techniques, membrane production manufacturing and market insights.
About GE Healthcare
GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement solutions, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention.
Headquartered in the United Kingdom, GE Healthcare is a $15 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 45,000 people committed to serving healthcare professionals and their patients in more than 100 countries.
About Parker domnick hunter
Parker domnick hunter’s Process Division provides novel filtration solutions for the many challenges faced by the biopharmaceutical industry. The company combines process engineering expertise with over four decades of experience in filtration systems and includes a team of dedicated pharmaceutical specialists.
Founded in 1963 and acquired by Parker in 2005, domnick hunter is an international group of companies dedicated to the provision of high quality filtration, separation and purification products for a wide range of industries and applications.
Excellence in technology and exporting has been recognized by 8 Queen's Awards to Industry. In 1987 domnick hunter became the first UK based filter company to achieve ISO 9001 registration.
Parker domnick hunter has trading subsidiaries and associates in 25 countries and ten manufacturing plants. Over 1900 people are employed worldwide with the specialized skills and experience in the development, manufacturing and application of filtration products.
Parker domnick hunter is part of the Parker Hannifin Corporation (Parker), a leading worldwide supplier in motion and control technologies and systems, providing precision engineered solutions for a wide variety of commercial, mobile, industrial and aerospace markets.
